1. Home
  2. IMCC vs LSBPW Comparison

IMCC vs LSBPW Comparison

Compare IMCC & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • LSBPW
  • Stock Information
  • Founded
  • IMCC 1980
  • LSBPW N/A
  • Country
  • IMCC Israel
  • LSBPW China
  • Employees
  • IMCC N/A
  • LSBPW N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMCC Health Care
  • LSBPW Health Care
  • Exchange
  • IMCC Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • IMCC 8.0M
  • LSBPW 7.4M
  • IPO Year
  • IMCC N/A
  • LSBPW N/A
  • Fundamental
  • Price
  • IMCC $2.48
  • LSBPW $0.06
  • Analyst Decision
  • IMCC
  • LSBPW
  • Analyst Count
  • IMCC 0
  • LSBPW 0
  • Target Price
  • IMCC N/A
  • LSBPW N/A
  • AVG Volume (30 Days)
  • IMCC 22.0K
  • LSBPW N/A
  • Earning Date
  • IMCC 08-12-2024
  • LSBPW N/A
  • Dividend Yield
  • IMCC N/A
  • LSBPW N/A
  • EPS Growth
  • IMCC N/A
  • LSBPW N/A
  • EPS
  • IMCC N/A
  • LSBPW N/A
  • Revenue
  • IMCC $54,288,541.00
  • LSBPW N/A
  • Revenue This Year
  • IMCC $11.51
  • LSBPW N/A
  • Revenue Next Year
  • IMCC $19.17
  • LSBPW N/A
  • P/E Ratio
  • IMCC N/A
  • LSBPW N/A
  • Revenue Growth
  • IMCC 12.87
  • LSBPW N/A
  • 52 Week Low
  • IMCC $1.13
  • LSBPW N/A
  • 52 Week High
  • IMCC $8.10
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 42.63
  • LSBPW N/A
  • Support Level
  • IMCC $1.80
  • LSBPW N/A
  • Resistance Level
  • IMCC $2.91
  • LSBPW N/A
  • Average True Range (ATR)
  • IMCC 0.25
  • LSBPW 0.00
  • MACD
  • IMCC -0.00
  • LSBPW 0.00
  • Stochastic Oscillator
  • IMCC 53.89
  • LSBPW 0.00

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: